Cybercrime has reached epidemic levels and continues to grow at a terrifying rate. Cybercrime damages are predicted to cost $6 trillion in 2021. Every day, the AV-Test Institute registers over 350,000 new malicious programs. Over 93% of these malicious programs are polymorphic, which means that they constantly change their code to evade detection by antivirus software.
Many people think that malware is created primarily by criminals for financial gain, and criminals account for much of the ransomware that cost its victims over $20 billion in 2020. However, malware is increasingly becoming a tool of warfare by nation-states. Russia and China use malware to attack the US government and US industry. Other major malware countries include Iran, North Korea, and India. The NSA receives over 300 million hacking attempts per day.
Why is malware so successful at infecting its victims? The answer lies with the antivirus industry’s primary method for detecting and blocking malware infections. Most antivirus software constantly scans the cloud for new strains of malware, adds them to their database, and uses that database to detect and block malware. Hackers defeat this methodology by constantly releasing new strains of malware – over a million per day – and writing polymorphic malware that can change itself to evade detection. These new strains successfully attack their victims before antivirus software detects the new malware, adds it to its database, and begins scanning for it. Antivirus software is always playing catch up and as the number of new strains released every day continues to rise, it becomes increasingly difficult for antivirus software to keep up. This technique for defeating malware just does not work.
Atense, a Cyber Defense startup based in Texas, has developed Computer Vaccine, which uses a methodology that does not require a database of malware and defeats ALL malware, even if it is already present on the computer. This is a disruptive new technology. Computer Vaccine is protected by 11 US patents, with additional patents pending in the US, China, India, and Europe.
You can participate in this new technology by investing as little as $100 through its equity crowdfunding campaign at www.wefunder.com/atense. You can be a shareholder in the company that may very well become a major cybersecurity player. For more information about Atense and Computer Vaccine, check out their website at www.atense.com.
